Amador Bioscience - Crunchbase Company Profile & Funding

Q: Who invested in Amador Bioscience?

Amador Bioscience has 5 investors including Cowin Venture And MSA Capital.

Q: When was the last funding round for Amador Bioscience?

Amador Bioscience closed its last funding round on obfuscated from a Series B round.

Q: How much funding has Amador Bioscience raised to date?

Amador Bioscience has raised obfuscated.

Overview

Amador Bioscience

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Amador Bioscience

CB Rank

24247

Amador Bioscience is a biotechnology company that offers bioanalysis and clinical research services.

Founded

obfuscation

Private

Series B

Pleasanton, California, United States

11-50

amadorbioscience.com

Biotechnology

Clinical Trials

Health Care

Life Science

Funding Rounds

Series B

OBF

obfuscation

Series B

OBF

obfuscation

Key People

Rong Zeng: Cofounder, COO
Haifeng Bao: Cofounder, Transitional Medicine Lead

Details

Legal Name

Amador Bioscience

Also Known As

安渡生物医药（杭州）有限公司

Operating Status

Active

Company Type

For Profit

Founders

Bing Wang, Haifeng Bao, Rong Zeng, Xiaomin Chen

About the Company

Amador Bioscience provides translational sciences and clinical pharmacology services to biopharmaceutical companies. Their services include bioanalysis, biomarker, and clinical research services. Their bioanalysis and biomarker services support drug development.

Phone Number

+1 925 558 2709

Contact Email

info@amadorbio.com

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

Bioanalysis and Biomarker Services

Provides bioanalytical testing and biomarker analysis across drug development phases using immunoassays, mass spectrometry, cell-based assays, flow cytometry, ELISpot, and molecular biology techniques.

Clinical Pharmacology Services

Delivers pharmacokinetic, pharmacodynamic, and pharmacometric analyses including modeling and simulation to optimize drug dosing and clinical trial design.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Amador Bioscience	4	obfuscated obfuscation	MSA Capital	Series B
obfuscated obfuscation	Series B - Amador Bioscience	4	obfuscated obfuscation	MSA Capital	Series B
obfuscated obfuscation	Series B - Amador Bioscience	4	obfuscated obfuscation	MSA Capital	Series B
obfuscated obfuscation	Series B - Amador Bioscience	4	obfuscated obfuscation	MSA Capital	Series B
obfuscated obfuscation	Series B - Amador Bioscience	4	obfuscated obfuscation	MSA Capital	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Amador Bioscience	4	obfuscated obfuscation	MSA Capital	Series B
obfuscated obfuscation	Series B - Amador Bioscience	4	obfuscated obfuscation	MSA Capital	Series B
obfuscated obfuscation	Series B - Amador Bioscience	4	obfuscated obfuscation	MSA Capital	Series B
obfuscated obfuscation	Series B - Amador Bioscience	4	obfuscated obfuscation	MSA Capital	Series B
obfuscated obfuscation	Series B - Amador Bioscience	4	obfuscated obfuscation	MSA Capital	Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Cowin Venture	—	Series B - Amador Bioscience	—
Cowin Venture	—	Series B - Amador Bioscience	—
Cowin Venture	—	Series B - Amador Bioscience	—
Cowin Venture	—	Series B - Amador Bioscience	—
Cowin Venture	—	Series B - Amador Bioscience	—

Investments

Investment Breakdown

Number of Acquisitions

Investment Breakdown

Number of Acquisitions

Market Intelligence

People

View Profiles & Contacts

Headcount

11-50

Employee Profiles

Contacts

Employee Profiles

Rong Zeng Cofounder, COO
Haifeng Bao Cofounder, Transitional Medicine Lead
Xiaomin Chen Cofounder, Senior Vice President
Meina Liang Chief Technology Officer (CTO), President of Bioanalysis & Biomarkers